Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

NCT03977467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Solid Tumor

Interventions

DRUG: Atezolizumab
DRUG: Standard of Care Chemotherapy
DRUG: Tiragolumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]